Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2001

Empirically derived subgroups of the EORTC-QLQ BR 23 – a clinically oriented assessment

Content (11 Articles)

Conference Report

Histologic multifocality is predictive of skin recurrences after conserving treatment of stage I and II breast cancers

Henri Marret, Franck Perrotin, Philippe Bougnoux, Bruno Giraudeau, Bruno Hubert, Franck Fetissof, Olivier Le Floch, Jacques Lansac, Gilles Body

Conference Report

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

Roberta D'Alessandro, Mario Roselli, Patrizia Ferroni, Sabrina Mariotti, Antonella Spila, Simona Aloe, Maria Daniela Carone, Maria Rosaria Abbolito, Sandro Carlini, Pasquale Perri, Andrea Ricciotti, Claudio Botti, Francesca Conti, Patrizia Vici, Neva Rossi Chiappetta, Francesco Cognetti, Oreste Buonomo, Fiorella Guadagni

Conference Report

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue

Heinz-Joachim List, Ronald Reiter, Baljit Singh, Anton Wellstein, Anna T Riegel

Conference Report

Solitary breast metastases from a renal cell carcinoma

Lucia Vassalli, Vittorio D. Ferrari, Edda Simoncini, Giovanni Rangoni, Elisabetta Montini, Patrizia Marpicati, Andrea Mambrini, Mauro Pagani, Cinzia Agazzi, Giovanni Marini

Conference Report

Tumor characteristics in African American and white women

Helena Furberg, Robert Millikan, Lynn Dressler, Beth Newman, Joseph Geradts

Conference Report

The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy

Kim M. Cecil, Mitchell D. Schnall, Evan S. Siegelman, Robert E. Lenkinski

Conference Report

VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells

Terry W. Moody, Julius Leyton, Daniel Chan, Douglas C. Brenneman, Mati Fridkin, Edgar Gelber, Albert Levy, Illana Gozes

Conference Report

Expression of pp32 gene family members in breast cancer

ShriHari S. Kadkol, Gamal Abou El Naga, Jonathan R. Brody, Jining Bai, Yuri Gusev, William C. Dooley, Gary R. Pasternack

Conference Report

Quality of life in breast cancer patients: a cluster analytic approach

G.C. Nagel, S. Schmidt, B.M. Strauss, D. Katenkamp

Breast cancer in Rubens paintings

Juan J. Grau, Jorge Estapé, Matías Diat-Padrón

Instructions for Authors

Breast Cancer Research and Treatment

Michele Alexander

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine